Rainbow Children's Medicare Limited RAINBOW NIFTY_SMALLNSEPHARMA

Healthcare · Medical Care Facilities · India

https://www.rainbowhospitals.in

Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.

Market & Price

Market Cap

₹14,001.78 Cr

Current Price

₹1,380.30

High / Low (52W)

₹1,623.90 / ₹1,103.80

Beta

0.13

Valuation

Stock P/E

50.25

Industry PE

37.60

Forward P/E

36.45

PEG Ratio

Book Value

₹149.47

Price to Book

9.23

P/S

8.22

EV/EBITDA

26.61

Dividend Yield

0.25%

Profitability & Returns

ROCE

16.83%

ROE

17.94%

ROA

9.55%

Profit Margin

16.34%

Op Margin

22.56%

EPS (Latest Qtr)

₹7.59

EPS (TTM)

₹27.47

Balance Sheet & Liquidity

Debt/Equity

0.54

Quick Ratio

3.21

Current Ratio

3.59

Debt

₹890.98 Cr

Total Assets

₹2,774.84 Cr

Current Assets

₹662.85 Cr

Working Capital

₹478.39 Cr

Ownership

Promoter Holding

53.76%

Chg in Prom Hold

FII / Inst Holding

36.29%

Chg in FII Hold

Financial Snapshot

Enterprise Value

₹14,478.97 Cr

Total Revenue (TTM)

₹1,703.08 Cr

EBITDA

₹544.17 Cr

Free Cash Flow

₹119.32 Cr

Operating Cash Flow

₹419.65 Cr

Shares Outstanding

₹10.14 Cr

Gross Margin

72.96%

Payout Ratio

10.94%

Growth (CAGR)

Revenue 5Y

13.63%

Profit 5Y

9.70%

Revenue (YoY)

24.30%

Earnings (YoY)

39.10%

PROS

Compounding revenue at 13.6% over 5 years.
Generates positive free cash flow.

CONS

Trading at a high P/E of 50.2.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP ₹	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	RAINBOW Rainbow Children's Medicare Limited NIFTY_SMALLNSEPHARMA	1,380.30	50.25	₹14,001.78 Cr	0.25%	16.83%	17.94%	13.63%	9.70%
2	SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA	1,799.20	37.59	₹4.32 L Cr	0.92%	17.94%	14.72%	10.39%	10.65%
3	DIVISLAB Divi's Laboratories Limited NSEPHARMA	6,667.00	68.97	₹1.77 L Cr	0.45%	18.96%	16.19%	11.27%	12.08%
4	TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA	4,410.80	68.96	₹1.49 L Cr	0.86%	9.06%	16.98%	13.27%	20.21%
5	CIPLA Cipla Limited NIFTY50NSEAIPHARMA	1,401.00	29.16	₹1.13 L Cr	0.93%	14.88%	11.74%	7.23%	11.45%
6	DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA	1,303.50	25.90	₹1.09 L Cr	0.61%	14.00%	11.83%	10.96%	-2.35%
7	ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA	1,077.70	21.51	₹1.08 L Cr	0.09%	19.24%	18.32%	16.55%	36.99%
8	LUPIN Lupin Limited NIFTY_MIDNSEPHARMA	2,267.70	19.49	₹1.04 L Cr	0.53%	28.42%	26.91%	19.10%	131.46%
9	MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA	2,375.60	51.29	₹98,090.71 Cr	0.08%	13.78%	12.45%	17.73%	14.28%

Quarterly Results

Figures in INR.

Metric	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	398.08 Cr	370.11 Cr	352.93 Cr	444.80 Cr	445.45 Cr	459.90 Cr
Cost of Revenue	-	53.73 Cr	47.04 Cr	47.50 Cr	62.21 Cr	60.33 Cr	56.98 Cr
Gross Profit	-	344.35 Cr	323.07 Cr	305.43 Cr	382.58 Cr	385.11 Cr	402.92 Cr
Operating Expenses	-	245.23 Cr	242.50 Cr	236.00 Cr	269.56 Cr	277.74 Cr	299.16 Cr
Operating Income	-	99.12 Cr	80.56 Cr	69.44 Cr	113.02 Cr	107.38 Cr	103.76 Cr
EBITDA	-	147.63 Cr	129.25 Cr	123.64 Cr	157.06 Cr	157.49 Cr	148.23 Cr
Interest Expense	-	18.07 Cr	18.12 Cr	18.08 Cr	18.85 Cr	20.20 Cr	20.50 Cr
Pretax Income	-	94.33 Cr	76.97 Cr	71.37 Cr	102.37 Cr	97.69 Cr	86.79 Cr
Tax Provision	-	25.39 Cr	20.42 Cr	17.57 Cr	26.75 Cr	23.80 Cr	8.57 Cr
Net Income	-	68.69 Cr	56.34 Cr	53.50 Cr	75.25 Cr	72.53 Cr	77.04 Cr
Diluted EPS	7.77	6.76	5.55	5.27	7.41	7.14	7.59

Profit & Loss (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue	-	1,160.80 Cr	1,285.69 Cr	1,515.87 Cr	1,703.08 Cr
Cost of Revenue	-	158.28 Cr	165.28 Cr	194.92 Cr	227.03 Cr
Gross Profit	-	1,002.52 Cr	1,120.41 Cr	1,320.95 Cr	1,476.05 Cr
Operating Expenses	-	687.93 Cr	796.84 Cr	969.50 Cr	1,082.45 Cr
Operating Income	-	314.60 Cr	323.57 Cr	351.45 Cr	393.60 Cr
EBITDA	-	426.62 Cr	465.95 Cr	540.90 Cr	586.42 Cr
Interest Expense	-	54.57 Cr	59.05 Cr	72.45 Cr	77.62 Cr
Pretax Income	-	281.78 Cr	294.81 Cr	330.00 Cr	358.23 Cr
Tax Provision	-	69.40 Cr	76.53 Cr	85.77 Cr	76.69 Cr
Net Income	-	210.83 Cr	217.00 Cr	243.42 Cr	278.32 Cr
Diluted EPS	13.62	20.89	21.38	23.84	-

Compounded Sales Growth

5 Years:	13.63%
1 Year:	24.30%

Compounded Profit Growth

5 Years:	9.70%
1 Year:	39.10%

Stock Price Performance

1 Year:	-1.16%
6 Months:	+3.78%
3 Months:	+13.41%
1 Month:	+9.18%

Balance Sheet (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Assets	-	1,770.72 Cr	2,170.40 Cr	2,376.99 Cr	2,774.84 Cr
Current Assets	-	477.88 Cr	621.63 Cr	822.05 Cr	662.85 Cr
Cash & Equivalents	-	16.96 Cr	10.12 Cr	20.25 Cr	33.89 Cr
Inventory	-	18.76 Cr	23.98 Cr	27.57 Cr	41.63 Cr
Receivables	-	62.97 Cr	75.47 Cr	79.39 Cr	103.18 Cr
Total Liabilities	-	705.81 Cr	905.48 Cr	901.98 Cr	1,111.25 Cr
Current Liabilities	-	138.87 Cr	149.46 Cr	150.57 Cr	184.46 Cr
Long Term Debt	27.31 Cr	0	-	-	-
Total Debt	-	570.32 Cr	765.31 Cr	763.58 Cr	890.98 Cr
Total Equity	-	1,059.91 Cr	1,258.93 Cr	1,468.19 Cr	1,648.07 Cr
Shares Outstanding	-	10.15 Cr	10.15 Cr	10.16 Cr	10.16 Cr

Cash Flows (Annual)

Figures in INR.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow	-	328.78 Cr	321.40 Cr	395.66 Cr	419.65 Cr
Investing Cash Flow	-	-465.20 Cr	-226.47 Cr	-267.80 Cr	-258.65 Cr
Financing Cash Flow	-	143.41 Cr	-101.78 Cr	-117.72 Cr	-147.37 Cr
Capital Expenditure	-	-141.30 Cr	-353.58 Cr	-145.67 Cr	-216.46 Cr
Free Cash Flow	-	187.49 Cr	-32.17 Cr	249.99 Cr	203.20 Cr
Net Change in Cash	-	6.99 Cr	-6.85 Cr	10.14 Cr	13.64 Cr

Ratios (Annual)

Figures in %.

Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Gross Margin %	-	86.4%	87.1%	87.1%	86.7%
Operating Margin %	-	27.1%	25.2%	23.2%	23.1%
Net Margin %	-	18.2%	16.9%	16.1%	16.3%
ROE %	-	19.9%	17.2%	16.6%	16.9%
ROCE %	-	19.3%	16.0%	15.8%	15.2%

Shareholding Pattern

Insiders

53.76%

Institutions

36.29%

Public Float

78.49%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for RAINBOW

No recent headlines available.

RAINBOW · Healthcare